{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:43:25Z","timestamp":1790844205426,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Context: Despite the importance of dihydrotestosterone in androgen action, polymorphisms in the genes for the two isoforms of 5\u03b1-reductase (SRD5A1 and SRD5A2) have not been evaluated as risk factors for polycystic ovary syndrome (PCOS).<\/jats:p><jats:p>Objective: The objective of the study was to test the hypothesis that haplotypes in the SRD5A1 and SRD5A2 genes are risk factors for PCOS and the severity of hirsutism in affected women.<\/jats:p><jats:p>Design: PCOS and control subjects were genotyped for seven single-nucleotide polymorphisms in SRD5A1 and eight single-nucleotide polymorphisms in SRD5A2. Haplotypes were determined and tested for association with PCOS diagnosis and component phenotypes.<\/jats:p><jats:p>Setting: Subjects were recruited from the reproductive endocrinology clinic at the University of Alabama at Birmingham; control subjects were recruited from the general surrounding community. Genotyping took place at Cedars-Sinai Medical Center in Los Angeles.<\/jats:p><jats:p>Participants: A total of 287 White women with PCOS and 187 controls participated.<\/jats:p><jats:p>Main Measurements: SRD5A1 and SRD5A2 genotype, quantitative hirsutism score, and hormonal and metabolic phenotypes were assessed.<\/jats:p><jats:p>Results: Haplotypes within both genes were associated with PCOS risk. The Leu allele of the Val89Leu variant in SRD5A2 was associated with protection against PCOS; this allele is known to modestly reduce 5\u03b1-reductase activity. Haplotypes in SRD5A1 but not SRD5A2 were also associated with the degree of hirsutism in affected women.<\/jats:p><jats:p>Conclusions: This study presents genetic evidence suggesting an important role of both isoforms of 5\u03b1-reductase in the pathogenesis of PCOS. That only SRD5A1 haplotypes were associated with hirsutism suggests that only this isoform is important in the hair follicle.<\/jats:p>","DOI":"10.1210\/jc.2006-0227","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:34:51Z","timestamp":1153269291000},"page":"4085-4091","source":"Crossref","is-referenced-by-count":77,"title":["Variants in the 5\u03b1-Reductase Type 1 and Type 2 Genes Are Associated with Polycystic Ovary Syndrome and the Severity of Hirsutism in Affected Women"],"prefix":"10.1210","volume":"91","author":[{"given":"Mark O.","family":"Goodarzi","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine (M.O.G., N.A.S., H.J.A.) Los Angeles, California 90048"},{"name":"Obstetrics and Gynecology (M.O.G., M.P., R.A.,), Los Angeles, California 90048"},{"name":"Medical Genetics Institute (M.O.G., X.G.), Cedars-Sinai Medical Center, Los Angeles, California 90048"},{"name":"Departments of Medicine (M.O.G., R.A.) Los Angeles, Los Angeles, California 90025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nissar A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine (M.O.G., N.A.S., H.J.A.) Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath J.","family":"Antoine","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine (M.O.G., N.A.S., H.J.A.) Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marita","family":"Pall","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology (M.O.G., M.P., R.A.,), Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[{"name":"Medical Genetics Institute (M.O.G., X.G.), Cedars-Sinai Medical Center, Los Angeles, California 90048"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology (M.O.G., M.P., R.A.,), Los Angeles, California 90048"},{"name":"Departments of Medicine (M.O.G., R.A.) Los Angeles, Los Angeles, California 90025"},{"name":"Obstetrics and Gynecology (R.A.), the David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California 90025"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613402105100_R1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.fertnstert.2005.01.096","article-title":"Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups","volume":"83","author":"Chang","year":"2005","journal-title":"Fertil Steril"},{"key":"2020071613402105100_R2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613402105100_R3","first-page":"2414","article-title":"5\u03b1-Reductase activity in women with polycystic ovary syndrome","volume":"84","author":"Jakimiuk","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613402105100_R4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0960-0760(96)00099-4","article-title":"5\u03b1-Reductase 1 and 2 expression and activity in human ovarian follicles, stroma and corpus luteum as compared to neonatal foreskin","volume":"59","author":"Haning Jr","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2020071613402105100_R5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(90)90664-Q","article-title":"5\u03b1-Reductase activity in polycystic ovary syndrome","volume":"335","author":"Stewart","year":"1990","journal-title":"Lancet"},{"key":"2020071613402105100_R6","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1210\/jc.2003-030240","article-title":"Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5\u03b1-reduction but not the elevated adrenal steroid production rates","volume":"88","author":"Tsilchorozidou","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613402105100_R7","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5\u03b1-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613402105100_R8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/JPEM.2000.13.3.253","article-title":"Increased 5\u03b1-reductase and normal 11\u03b2-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome","volume":"13","author":"Chin","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2020071613402105100_R9","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992","journal-title":"In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Cambridge, UK: Blackwell Scientific;"},{"key":"2020071613402105100_R10","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613402105100_R11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613402105100_R12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"2020071613402105100_R13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"2020071613402105100_R14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2020071613402105100_R15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nature02168","article-title":"The International HapMap Project","volume":"426","author":"The International HapMap Consortium","year":"2003","journal-title":"Nature"},{"key":"2020071613402105100_R16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.GIM.0000076971.55421.AD","article-title":"Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans","volume":"5","author":"Goodarzi","year":"2003","journal-title":"Genet Med"},{"key":"2020071613402105100_R17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1050-3862(98)00019-9","article-title":"Allelic discrimination using fluorogenic probes and the 5\u2032 nuclease assay","volume":"14","author":"Livak","year":"1999","journal-title":"Genet Anal"},{"key":"2020071613402105100_R18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"2020071613402105100_R19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/344207","article-title":"Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms","volume":"71","author":"Qin","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2020071613402105100_R20","first-page":"664","article-title":"Gene analysis of steroid 5\u03b1-reductase 1 in hyperandrogenic women","volume":"46","author":"Eminovic","year":"2005","journal-title":"Croat Med J"},{"key":"2020071613402105100_R21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0306-3356(21)00139-4","article-title":"Disturbances of androgen secretion and metabolism in polycystic ovary syndrome","volume":"12","author":"Lobo","year":"1985","journal-title":"Clin Obstet Gynaecol"},{"key":"2020071613402105100_R22","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0015-0282(16)55316-3","article-title":"Cutaneous application of an androstenedione gel as an in vivo test of 5\u03b1-reductase activity in women","volume":"58","author":"Miles","year":"1992","journal-title":"Fertil Steril"},{"key":"2020071613402105100_R23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","author":"Kiddy","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613402105100_R24","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/0002-9378(89)90954-X","article-title":"Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome","volume":"161","author":"Matteri","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"2020071613402105100_R25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1590\/S0100-879X2003001000024","article-title":"The 5\u03b1-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals","volume":"36","author":"Oliveira","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"2020071613402105100_R26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000211412","article-title":"Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit","volume":"9","author":"Courchay","year":"1996","journal-title":"Skin Pharmacol"},{"key":"2020071613402105100_R27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1034\/j.1600-0625.2002.110106.x","article-title":"Type-1 steroid 5\u03b1-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5\u03b1-reductase","volume":"11","author":"Gerst","year":"2002","journal-title":"Exp Dermatol"},{"key":"2020071613402105100_R28","first-page":"1989","article-title":"Predominant expression of 5\u03b1-reductase type 1 in pubic skin from normal subjects and hirsute patients","volume":"81","author":"Mestayer","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613402105100_R29","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/humrep\/14.8.1934","article-title":"Increased peripheral androgen activity in infertile Korean women with polycystic ovaries","volume":"14","author":"Roh","year":"1999","journal-title":"Hum Reprod"},{"key":"2020071613402105100_R30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/B:REMD.0000021437.46773.26","article-title":"Candidate genes for type 2 diabetes","volume":"5","author":"Parikh","year":"2004","journal-title":"Rev Endocr Metab Disord"},{"key":"2020071613402105100_R31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPAR\u03b3 Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat Genet"},{"key":"2020071613402105100_R32","first-page":"185","article-title":"The association between polymorphisms in the CYP17 and 5\u03b1-reductase (SRD5A2) genes and serum androgen concentrations in men","volume":"10","author":"Allen","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020071613402105100_R33","first-page":"1077","article-title":"Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study","volume":"10","author":"Hsing","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020071613402105100_R34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00008571-200007000-00004","article-title":"Biochemical and pharmacogenetic dissection of human steroid 5\u03b1-reductase type II","volume":"10","author":"Makridakis","year":"2000","journal-title":"Pharmacogenetics"},{"key":"2020071613402105100_R35","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00345-003-0378-4","article-title":"Genetic polymorphisms and prostate cancer risk","volume":"21","author":"Gsur","year":"2004","journal-title":"World J Urol"},{"key":"2020071613402105100_R36","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1210\/jc.2005-0446","article-title":"The valine allele of the V89L polymorphism in the 5-\u03b1-reductase gene confers a reduced risk for hypospadias","volume":"90","author":"Thai","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613402105100_R37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.ejhg.5201232","article-title":"Mutation analysis of five candidate genes in Chinese patients with hypospadias","volume":"12","author":"Wang","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"2020071613402105100_R38","first-page":"417","article-title":"Steroid 5-\u03b1 reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study","volume":"11","author":"Pearce","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020071613402105100_R39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2265.1996.00828.x","article-title":"How robust is the methodology for trials of therapy in hirsute women?","volume":"45","author":"Barth","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613402105100_R40","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1210\/jc.2004-2243","article-title":"Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome","volume":"90","author":"Wild","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/10\/4085\/9064636\/jcem4085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/10\/4085\/9064636\/jcem4085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T22:15:59Z","timestamp":1627596959000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/10\/4085\/2656620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-0227","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}